Astellas Pharma | 4503 - Ebit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Astellas Pharma

Astellas Pharma reported JPY-48143000000 in EBIT for its fiscal quarter ending in March of 2023.


Ebit Change
Astellas Pharma 4503:JP JPY -48143000000 110.89B
Chugai Pharma 4519:JP JPY 98.3B 51.18B
Daiichi Sankyo 4568:JP JPY -6551000000 38.1B
Eisai 4523:JP JPY 26.22B 17.65B
Kyowa Hakko Kirin 4151:JP JPY 13.82B 7.78B
M3 Inc 2413:JP JPY 13.08B 8.68B
Otsuka Holdings 4578:JP JPY 71.35B 27.14B
Shionogi 4507:JP JPY 2.53B 115.72B
Sumitomo Dainippon 4506:JP JPY -59202000000 71.95B
Takeda 4502:JP JPY 88.56B 73.33B
Terumo 4543:JP JPY 23.82B 13.72B